Analysis Of Income And Expense [Abstract]

Generix Group S.A. - Filing #2815373

Concept	2021-04-01 to 2022-03-31	2020-04-01 to 2021-03-31
Analysis of income and expense [abstract]
Revenue [abstract]
Other revenue	4 619 EUR	3 963 EUR
Revenue	89 122 EUR	84 218 EUR
Material income and expense [abstract]
Finance income (cost)	144,000 EUR	124,000 EUR
Expenses by nature [abstract]
Raw materials and consumables used	860,000 EUR	803,000 EUR
Services expense	17 522 EUR	17 206 EUR
Classes of employee benefits expense [abstract]
Employee benefits expense	55 901 EUR	50 849 EUR
Depreciation, amortisation and impairment loss (reversal of impairment loss) recognised in profit or loss [abstract]
Depreciation and amortisation expense [abstract]
Depreciation and amortisation expense	4 992 EUR	4 558 EUR
Tax expense other than income tax expense	2 219 EUR	1 990 EUR
Disclosure of attribution of expenses by nature to their function [text block]	—	—
Disclosure of attribution of expenses by nature to their function [abstract]
Disclosure of attribution of expenses by nature to their function [line items]
Miscellaneous other comprehensive income [abstract]
Other comprehensive income, before tax, exchange differences on translation of foreign operations and hedges of net investments in foreign operations [abstract]
Other comprehensive income, before tax, exchange differences on translation of foreign operations	569,000 EUR	628,000 EUR
Comprehensive income, continuing and discontinued operations [abstract]
Comprehensive income	5 600 EUR	5 580 EUR
Comprehensive income attributable to owners of parent, continuing and discontinued operations [abstract]
Comprehensive income, attributable to owners of parent	4 474 EUR	4 657 EUR
Comprehensive income attributable to non-controlling interests, continuing and discontinued operations [abstract]
Comprehensive income, attributable to non-controlling interests	1 126 EUR	923,000 EUR